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Vascular endothelial cells are subjected to hemodynamic forces such as mechanical stretch due to the pulsatile
nature of blood flow. Mechanical stretch of different intensities is detected by mechanoreceptors on the cell
surface which enables the conversion of external mechanical stimuli to biochemical signals in the cell, activating
downstream signaling pathways. This activation may vary depending on whether the cell is exposed to
physiological or pathological stretch intensities. Substantial stretch associated with normal physiological functioning
is important in maintaining vascular homeostasis as it is involved in the regulation of cell structure, vascular
angiogenesis, proliferation and control of vascular tone. However, the elevated pressure that occurs with
hypertension exposes cells to excessive mechanical load, and this may lead to pathological consequences through
the formation of reactive oxygen species, inflammation and/or apoptosis. These processes are activated by
downstream signaling through various pathways that determine the fate of cells. Identification of the proteins
involved in these processes may help elucidate novel mechanisms involved in vascular disease associated with
pathological mechanical stretch and could provide new insight into therapeutic strategies aimed at countering the
mechanisms’ negative effects.Introduction
Blood vessels consist of three primary layers: the tunica
intima, the tunica media and the tunica adventitia. The
tunica intima is the innermost layer that contains the
endothelium (endothelial cell (EC) layers) that provides
a smooth surface for blood flow, whereas the tunica
media contains thick layers of elastin, collagen and
smooth muscle cells (SMCs) for vascular dilation or
constriction. The outermost layer, the tunica adventitia,
is composed of a mixture of connective tissue, collagen
and elastic fibers and is used for arterial support.
Hemodynamic forces, such as shear and tensile stress,
continuously act upon blood vessels due to the pumping
motion of the heart. Specifically, shear stress arises from
the friction of the blood flow with the endothelial layer,
whereas tensile stress primarily acts upon the medial* Correspondence: mark.baker@mq.edu.au
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pumped from the heart.
Mechanical stretch enables vascular maintenance
through proliferation, angiogenesis, the formation of react-
ive oxygen species, control of vascular tone and vascular
remodeling [1–6]. However, the excessive mechanical
stretch that occurs during hypertension has been shown to
be detrimental as it perturbs these processes and causes
inappropriate cellular responses that can lead to cardiovas-
cular abnormalities [7]. As such, mechanical stretch has
been modeled in vitro by regulating stretch intensity to
simulate physiological and pathological stretch magnitudes
(the percentage of the cell elongation from the cell’s
original dimensions). Low magnitude stretches of 5–10 %
are categorized as physiological stretch, whereas high mag-
nitude stretches of 20 % and above are considered patho-
logical stretch and are thought to simulate what is
proposed to occur during hypertension [8]. The differences
in stretch intensity may activate different downstream
signaling pathways that determine the cells’ functional, bio-
logical and phenotypic features.distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Jufri et al. Vascular Cell  (2015) 7:8 Page 2 of 12Previous studies have focused on the effect of shear
stress and its pathological implications on EC. However,
the effect of tensile stretch (specifically on human vascu-
lar ECs), has not been studied in depth [9–12]. For this
reason, this review will focus on the current research in
mechanotransduction specifically as it relates to vascular
ECs. There will be a particular emphasis on receptors
involved in sensing mechanical stretch; the signal trans-
duction pathways involved that result in extracellular
matrix (ECM) remodeling, angiogenesis, cell prolifera-
tion, vascular tone homeostasis, reactive oxygen species
formation, inflammation and apoptosis (Table 1). In
addition, the review will attempt to relate how these
functions are thought to be associated with the develop-
ment of disease. Finally, we will briefly discuss the direc-
tion of future research in this field.
Mechanical stretch receptors induce signal transduction
Mechanical stretch generates a cascade of biochemical
signaling processes in ECs. The fundamental paradigm is
that mechanoreceptors on the plasma membrane of
ECs, through a series of signaling pathways, induce gene
expression and protein synthesis to promote or ablate
processes such as angiogenesis, proliferation, inflamma-
tion, apoptosis, vascular tone and cell survival.
Biochemically, mechanotransduction of stretch is de-
tected by three known mechanoreceptor proteins that
are distributed throughout the cell: stretch activated
(SA) channel, integrin proteins and the platelet endothe-
lial cell adhesion molecule-1 (PECAM). The SA channel
is located on the plasma membrane and has been shown
to participate in calcium (Ca2+) influx in response to
stretch that later initiates PI3K activation mediated by
Rho and Rho-associated kinase (ROCK) for cellular
orientation [13, 14]. Studies on the SA channel have
determined that the specific ion channel known as the
transient receptor potential (TRP) is responsible for the
Ca2+ influx [13]. The transient receptor potential vanil-
loid channel 4 (TRPV4) is found to be highly expressed
in ECs. Meanwhile, brain ECs specifically exhibit transi-
ent receptor potential classical 1 (TRPC1) and transient
receptor potential polycystin 2 (TRPP2) [15]. Knock-
down of TRPP2 has been found to inhibit the Ca2+
influx, and this leads to disruption of blood–brain bar-
rier integrity and to edema [16].
Integrins are the second known type of mechanore-
ceptors that act by transmitting stretch signals from
the ECM into the cell. Integrins are transmembrane
heterodimeric glycoproteins consisting of one of 8 dif-
ferent α and one of 18 different β subunits. They attach
the cell to the ECM and to proteins located within the
matrix (e.g., latent TGFβ1 for ITGB6). Stretch-exposed
HUVECs express higher levels of the endothelial cell
integrin αVβ3 through P13K activation, suggestingenhanced adhesiveness of the cells to RGD (tripeptide
of L-arginine, glycine, and L-aspartic acid)-containing
ECM substrates such as fibronectin [17, 18]. As
integrin-ECM binding is increased, it stimulates an
increased level of Ca2+ influx that is associated with
promoting phosphorylation of focal adhesion kinase
(FAK) and Src family kinases proximal to the inner
surfaces of the integrin. FAK is one of the components
of the focal adhesion complex which is composed of a
group of proteins (i.e., zyxin, vinculin, talin, paxillin
and actinin) that function together to connect the
ECM and integrins to the cytoskeleton at the plasma
membrane [19]. In addition, mechanical stretch in-
duces Src tyrosine kinase activation of molecules local-
ized to the focal adhesion (FA), and this appears to be
central to signal transduction pathways and changes
actin organization in HUVECs [20].
The third class of proteins that act as a mechanorecep-
tors is the platelet endothelial cell adhesion molecule-1
(PECAM-1), also known as CD31. It is a cell adhesion
molecule that is abundantly expressed in ECs, especially
in regions of cell-to-cell contact [21]. It is suggested that
the application of a specific force generates EC deform-
ation, and PECAM-1 is able to sense this change from
the neighboring cells through PECAM-1 tyrosine phos-
phorylation. This is then followed by activation of the
extracellular signal-related kinase 1/2 (ERK1/2) signaling
cascade via P21ras and Raf-1 [21–23]. In addition,
PECAM-1 phosphorylation initiates SHP-2 binding to ac-
tivate MAPK and ERK1/2 pathways that promote cellular
reorientation [24, 25]. Expression of these mechanorecep-
tor proteins across the EC indicates that sensing the force
is a crucial initial step to activate mechanotransduction.
Morphology and structural changes induced by
mechanical stretch
The morphological and structural changes in cells are
primarily determined by the cytoskeleton and focal
adhesion complexes. One of the distinct responses of
ECs exposed to stretch is the emergence of a bundle of
10–30 actin filaments, known as stress fibers, which
contribute to resistance against the applied stress and
transmit mechanotransduction in non-muscle cells
[26–28]. ECs cultured under static conditions exhibit a
polygonal shape and are randomly orientated. However,
two main morphological changes are observed when
mechanical stretch is applied to ECs. First, cells become
elongated and second, become slanted to a particular
angle usually perpendicular to the stretch direction due
to stress fiber reorientation (Fig. 1) [14, 29–32]. Previ-
ous studies have determined that the perpendicular
stress fibers’ orientation serves to maintain the cell
structure for minimizing alterations in intracellular
strain by bearing less tension [33, 34]. This orientation
Table 1 Mechanical stretch induces various biological processes in endothelial cells
Cell
type
Stretch intensity Observation/Measurement Biological process Reference
1 HUVEC 10 % ↑ actin Morphology Yoshigi et al. 2003 [29]
2 HUVEC 10 % Cells oriented 65 ° to stretch direction Morphology Barron et al. 2007 [32]
3 HUVEC 0–110 % Cells oriented 47.8 ° at 100 % Morphology Takemasa et al. 1998 [27]
4 HAEC 10 % Cells oriented at 70/90 ° Morphology Wang et al. 2001 [34]
5 HUVEC 0–25 % Cells oriented at 60–70 ° at 10–15 % stretch Morphology Haghighipour et al. 2010 [94]
6 HUVEC 10 % Perpendicular cell’s orientation Morphology Moretti et al. 2004 [31]
7 HUVEC 20 % Paxillin needed for initial cell orientation Morphology Huang et al. 2012 [30]
8 BAEC 1–10 % Rho proteins for perpendicular alignment Morphology Kaunas et al. 2005 [35]
9 BAEC 1–10 % ↑ JNK (2.6-fold) at 30 min Morphology Kaunas et al. 2006 [36]
10 HUVEC 120 % ↑ CAMP (3-fold) Morphology Yamada et al. 2000 [96]
11 HUVEC Local stretch by
microneedle
↑ Src homology 2-containing tyrosine phosphatase Morphology Ueki et al. 2009 [25]
12 BAEC 5–30 % ↑ Hsp 25 (relative activity 40 %) Morphology Luo et al. 2007 [38]
↑ Hsp 70 (relative activity 60 %)
13 BAEC 10 % ↑ JNK (5-fold) Morphology Hsu et al. 2010 [37]
↑ ERK (4-fold)
↑ p38 (4-fold)
14 HUVEC 120 % ↑ Ca2+ Calcium influx Naruse et al. 1998 [14]
15 BCE 10/15 % ↑ Ca2+ (2-fold) via transient receptor potential vanilloid 4 Calcium influx Thodeti et al. 2009 [13]
16 bEND 20/35/55 % ↑ Ca2+ via transient receptor potential channels Calcium influx Berrout et al. 2012 [16]
17 HUVEC 20 % ↑ c-src (3.2-fold) at 15 min Mechanotransduction Naruse et al. 1998 [97]
18 HUVEC 20 % ↑ pp125FAK Mechanotransduction Naruse et al. 1998 [98]
19 BAEC 10 % ↑ p21ras (24.7 % ratio) at 1 min Mechanotransduction Ikeda et al. 1999 [22]
20 HUVEC 20 % ↑ tyrosine phosphorylation (>2000 arbitrary unit) Mechanotransduction Katanosaka et al. 2008 [20]
21 BAEC 5–25 % ↑ ERK at 15 mins Mechanotransduction Shi et al. 2007 [23]
22 HUVEC 120 % ↑ integrin beta-3 (171 %) at 4 h Adhesive Suzuki et al. 1997 [17]
23 HAEC 5–20 % ↑ Akt phosphorylation at 5 %, 10 min (6000 arbitrary unit) Apoptosis Kou et al. 2009 [77]
↑ Akt phosphorylation at 20 %, 30 min (1000 arbitrary
unit)
24 BAEC 6–10/20 % ↑ Akt phosphorylation and ↑ Bad phosphorylation in
presence of TNFα at 6 %
Apoptosis Liu et al. 2003 [45]
25 BAEC 10 % ↑ Akt phosphorylation at Ser 473 at 30–60 mins Apoptosis Nishimura et al. 2006 [78]
26 BAEC 10 % ↑ S6K phosphorylation (1.5-fold) at 30 mins Proliferation Li and Sumpio 2005 [1]
27 BAEC 20 % ↑ Rac1 (5-fold) Proliferation Liu et al. 2007 [56]
28 HUVEC 20 % ↑ c-Myc (2–3-fold) at 1–2 h Proliferation Hurley et al. 2010 [57]
29 Vein
graft
15 % ↑ Egr-1 (5.5-fold) at 90 mins Proliferation Zhang et al. 2013 [58]
HUVEC 20 % ↑ MMP-2 (3.7-fold) at 18 h Extracellular matrix Wang et al. 2003 [44]
↑ MMP-14 (3-fold) at 18 h
30 BAEC 5 % ↑ MMP-2 (8-fold) at 8 h Extracellular matrix von Offenberg Sweeney
et al. 2004 [43]
31 BCEC 0–28 % ↑ pro MMP-2 Extracellular matrix Shukla et al. 2004 [99]
32 HUVEC 15 % ↑ MCP-1 (200 %) at 6 h Inflammation Demicheva et al. 2008 [100]
33 HUVEC 125/150 % ↑ IL-6 (3-fold) at 90 min Inflammation Kobayashi et al. 2003 [75]
34 HUVEC 0–10 % ↑ COX-2 (2.5-fold) at 3 h Inflammation Zhao et al. 2009 [101]
↑ thromboxane A2 synthase (150 %)
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Table 1 Mechanical stretch induces various biological processes in endothelial cells (Continued)
35 HUVEC 120–150 % ↑ von Willebrand factor to 5 mU/L at 60 min Inflammation Xiong et al. 2013 [74]
36 HUVEC 6–15 % ↑ IL-8 (2.6-fold) Inflammation Okada et al. 1998 [80]
↑ MCP-1 (2.8-fold)
37 HUVEC 12–25 % ↓ MCP-1 by exposure of nitric oxide donor Inflammation Wung et al. 2001 [102]
38 BAEC 0–10 % MMP-9 silencing block migration and tube formation Angiogenesis von Offenberg Sweeney
et al. 2005 [55]
39 BAEC 10 % Endothelial cord aligning to 67.5–90° Angiogenesis Joung et al. 2006 [2]
40 HUVEC 6–13 % ↑ Ang-2 (4.8-fold) Angiogenesis Yung et al. 2009 [54]
PDGF-ββ (↑ 5.0-fold)
41 CMEC 10 % ↑ VEGF (1.4-fold) Angiogenesis Zheng et al. 2001 [51]
42 CMEC 10 % ↑ VEGF-R2 (3.2-fold) Angiogenesis Zheng et al. 2008 [48]
↑ Tie-2 (1.8-fold)
43 BAEC 10/20 % ↑ angiogenesis Angiogenesis Wilkins et al. 2014 [52]
44 HUVEC 15 % ↑ Flk-1 (1.7-fold) Angiogenesis Zheng et al. 2004 [47]
↑ Tie-1 (2-fold)
↑ Tie-2 (1.9-fold)
45 HUVEC 10 % ↑ Alpha smooth muscle actin (1.6-fold) Transdifferentiation Shoajei et al. 2014 [84]
↑ Smooth muscle myosin heavy chain (1.3-fold)
46 HUVEC 10 % ↑ Alpha smooth muscle actin (165 %) Transdifferentiation Cevallos et al. 2006 [83]
↑ Caldesmon-1 (443 %)
↑ Smooth muscle myosin heavy chain (205 %)
↑ Calponin-1 (174 %)
47 HUVEC 10/20 % ↑ Young’s modulus of elasticity Stiffening Hatami et al. 2013 [82]
48 BAEC 120 % ↑ eNOS phosphorylation (1.8 arbitrary unit) Vascular tone Takeda et al. 2006 [62]
↑ NO (1.4-fold)
49 HUVEC 20–50 % ↑ eNOS (7-fold) at 50 % Vascular tone Hu et al. 2013 [5]
50 HUVEC 25 % ↑ Et-1 (2.3-fold) Vascular tone Cheng et al. 2001 [4]
51 HUVEC 10 % ↑ Et-1 (1.6-fold) Vascular tone Toda et al. 2008 [64]
52 HUVEC 6 % ↑ 8,9-epoxyeicosatrienoic acid (EET) (4–8-fold) Vascular tone Fisslthaler et al. 2001 [63]
53 HUVEC 100–250 % ↑ glutathione peroxidase to 200 % ROS Wagner et al. 2009 [71]
54 HAEC 8–20 % ↑ p66Shc (150–200-fold) ROS Spescha et al. 2014 [70]
55 HUVEC 5–12 % ↓ Nox4 (40 %) 12 %, 24 h ROS Goettsch et al. 2009 [67]
↑ eNOS (3-fold) at 12 %, 24 h
↑ NO (2 uM) at 5 %, 24 h
56 HUVEC 25 % ↑ ROS (221 %), 6 h ROS Ali et al. 2004 [68]
↑ VCAM-1
57 BAEC 25 % ↑ FAK phosphorylation ROS Ali et al. 2006 [66]
HUVECs Human umbilical vascular endothelial cells, HAECs Human aortic endothelial cells, BAECs Bovine arterial endothelial cells, BCE Bovine capillary endothelial
cells, bEND Brain microvessel endothelial cells, BCECs Brain capillary endothelial cells, CMECs Coronary microvascular endothelial cells
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inhibition of Rho perturbs the perpendicular orienta-
tion of stress fibers [35].
The perpendicular orientation of early phase ECs is
mediated by paxillin, one of the signaling structural scaf-
fold proteins found in the FA complex [30]. Knockdownof paxillin abolishes the perpendicular orientation of
stretched HUVECs, suggesting it plays a pivotal role in
aligning stress fibers during stretch [30]. Equally, stretch-
ing increases JNK and ERK phosphorylation during the
early stages of stress fiber orientation, and these levels
subside after the stress fiber is oriented perpendicular to
BA
Fig. 1 Morphological change of human cerebral microvascular endothelial cells (HCMECs). The HCMECs were stained with Alexa 594 (red) for
actin, and the nucleus was stained by DAPI (blue). a HCMECs that were not exposed to stretch were rounded in shape. b HCMECs that were
exposed to 18 h cyclic stretch became elongated in shape
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tein 70 (HSP70) expression has also been shown to be in-
creased by stretch and its inhibition shown to inhibit EC
stress fiber formation [38]. Thus, these intracellular signals
are suggestive of complex processes involved in the regu-
lation of stress fibers in determining EC morphology when
they are subjected to mechanical stretch.
Extracellular matrix remodeling by mechanical stretch
The ECM comprises a mixture of molecules, such as
collagen, elastin, proteoglycans, laminin and fibronec-
tin that provide structural support, adhesion sites and
transmission of biochemical signals to surrounding
cells [39]. Synthesis and degradation of ECM is an es-
sential part of the vascular remodeling process for
homeostasis and during physiological and pathological
responses. Zinc-dependent endopeptidases from the
matrix metalloproteinase (MMP) protease family can
induce the breakdown of ECM if the zymogen MMPs
are activated physiologically [40–42]. MMPs contribute
to vascular remodeling through vascular adaptation,
angiogenesis and repair during physiological stretch.
Physiological stretch increases MMP-2 expression in
bovine arterial endothelial cells (BAEC), and this is
thought to be mediated by the Gβγ/p38 and PTK/Shc/
ERK pathways [43]. By contrast, pathological stretch
increases both MMP-2 and MMP-14 in HUVECs, and
this was shown to be mediated through the TNF-α and
JNK pathways [44, 45]. MMP activity during patho-
logical stretch is thought to contribute to atheroscler-
osis as it facilitates the migration of vascular smooth
muscle cells into the intima layer where further prolif-
eration contributes to plaque formation [46].
Physiological stretch induces angiogenesis
Vascular ECs are known to play a major role in angio-
genesis as they are involved in vessel cord formation,
sprouting, migration and tube formation, and this ap-
pears to be facilitated by a series of chemical stimuli
(Table 1). Several processes involved in angiogenesishave been associated with physiological stretch. For ex-
ample, physiological stretch has been found to upregu-
late key tyrosine kinase receptors such as Flk-1, Tie-2
and Tie-1 in both HUVECs and RCMECs [47, 48].
These receptors are sensitive to growth factors and act
to induce the formation of new blood vessel.
In addition, stretch stimulates the secretion of angio-
genic factors that circulate in a paracrine or autocrine
manner in the vascular system [49, 47]. Physiological
stretch has been reported to increase the secretion of
vascular endothelial growth factor (VEGF) and the
expression of its receptor, VEGF-R2 (Flk-1) [49]. Both of
these are key proteins needed for cell proliferation and
tube formation during HUVEC angiogenesis [50, 51]. In
addition, basic fibroblast growth factor (bFGF) was also
increased and found to promote sprouting during angio-
genesis when ECs were subjected to stretch [52]. bFGF
may be released at the initial state of angiogenesis before
being replaced by VEGF to complete the angiogenesis
process [53]. Furthermore, physiological stretch was
found to activate endogenous biochemical molecules
such as angiopoietin-2 and platelet derived growth factor
ββ (PDGF-ββ) that may be involved in endothelial cell
migration and sprout formation [54]. EC migration and
tube formation were also increased during stretch due to
the activation of Gi protein subunits and increased
GTPase activity which facilitates angiogenesis [55].
Taken together, these results show that physiological
stretch is intimately involved in evoking vasculature an-
giogenic processes across the vascular system.
Mechanical stretch stimulates EC proliferation
Cell proliferation is a fundamental process for replacing
old and damaged cells and represents an important part
of tissue homeostasis and stretch is thought to influ-
ence this biological function (Table 1). Exposure to
physiological stretch in BAECs was found to induce cell
proliferation, mediated by the P13K-dependent S6K
mTOR-4E-BP1 pathway [1]. The mammalian target of
rapamycin (mTOR) is an important key translational
Jufri et al. Vascular Cell  (2015) 7:8 Page 6 of 12pathway that regulates cell cycle, proliferation and
growth. In addition, cell-to-cell adhesion is required for
ECs to proliferate during stretch. This cell-to-cell adhe-
sion is principally mediated by cadherins that transduce
mechanical forces through Rac1 activation [56]. This
may limit stretch-mediated EC proliferation as it occurs
only in the presence of adjacent cells and serves as a
mechanism to prevent ECs from displaying elements of
invasive behavior and/or excessive proliferation [56].
However, uncontrolled proliferation of ECs has been
observed in pathological stretch as the expression of
the oncogene c-Myc was upregulated in HUVEC [57].
This could be a major contributor to vascular disease
as it could lead to the intimal thickening that increases
vascular resistance and blood pressure. In addition,
the observation that early growth response protein-1
(Egr-1) promotes proliferation during stretch in vein
graft models supports the suggestion that pathological
stretch plays a role in restenosis [58]. Thus, future
strategies aimed at targeting these proteins may be of
therapeutic value for controlling cell proliferation that
originates from hypertension.
Expression of vasoconstrictors and vasodilators during
stretch
Blood vessels depend on numerous vasodilating and
vasoconstricting protein factors to regulate vascular tone
through the homeostatic balancing of blood pressure
(Table 1). Endothelin 1 (ET-1) is a potent vasoconstrictor
produced by vascular ECs. The endothelium-derived
hyperpolarizing factor (EDHF) induced by epoxyeicosa-
trienoic acid (EET) generated by the cytochrome P450
(CYP) epoxygenase enzyme subfamily is another vaso-
constrictor that functions to increase blood pressure
[59, 60]. On the other hand nitric oxide (NO) plays an
important role in vasodilation and is generated from the
conversion of L-arginine to L-citrulline by phosphory-
lated endothelial nitric oxide synthase (eNOS) [61]. The
synthesis of eNOS is controlled by stretch, and its
production is dependent on Ca2+ influx. Specifically, a
decrease of Ca2+ elicited by an inhibitor of the SA chan-
nel was shown to inhibit eNOS phosphorylation [62].
Physiological stretch was found to increase ET-1 mRNA
levels in HUVECs, whereas EET and CYP 2C mRNA
expression for the generation of EDHF was increased in
the coronary artery of ECs [63]. Pathological stretch was
found to increase ET-1 in HUVECs [4, 64] whereas eNOS
and NO were increased in BAECs and HUVECs [5, 62].
Several mechanisms have been proposed for the regula-
tion of NO expression, such as an increase of Ca2+ con-
centration via the stretch-activated channel at the early
phase of stretch followed by eNOS phosphorylation via
the PKA pathway and activation of the P13K-Akt/PKB
pathway in the late stage of stretch [5, 62, 65]. NO hasanti-atherogenic properties, as it inhibits transcription
factors that regulate expression of pro-atherogenic or
pro-inflammatory genes. However, the balance of NO
might be altered in pathological stretch as the ROS
levels are often elevated significantly in this condition
and results in reduced levels of NO. Thus, stretch intensity
is an important factor in determining ROS balance to
ensure healthy cellular function in the vascular system.
Increased production of reactive oxygen species by
pathological stretch
Cells continuously produce ROS as a by-product of nor-
mal mitochondrial electron transfer. There are several
forms of ROS, such as superoxide anions (O2
−), peroxyni-
trite anions (ONOO−) and hydroxyl radicals (−OH) with
the most common being hydrogen peroxide (H2O2) a
by-product of superoxide dismutation. At physiological
concentrations, these short-lived reactive intermediates
are involved in microbial defense, signal transduction
and regulation of the cell cycle (Table 1). ROS act as sec-
ond messengers in signal transduction cascades includ-
ing those that mediate FAK phosphorylation and are
necessary for cell motility and survival [66]. Physiological
stretch results in a decrease in superoxide anion produc-
tion, as Nox4 expression is reduced in HUVECs. In ECs,
Nox4-containing NAD(P)H oxidase complexes have
been identified as a major source of superoxide anion
formation. However, physiological stretch was found to
suppress Nox4, increase NO release and reduce ROS
formation, suggesting it performs a vasoprotective role
[67]. However, increased levels of ROS in pathological
stretch can induce pro-atherogenic or pro-inflammatory
conditions in HUVECs. Pathological stretch produces
excessive O2
− that can react alone or through the enzyme
superoxide dismutase to generate H2O2 [68]. H2O2 later
activates NFκB and the subsequent transcriptional activ-
ity of adhesion molecules such as VCAM-1. This
promotes pro-inflammatory activity that leads to athero-
sclerosis formation over time [69]. In addition, patho-
logical stretch was found to phosphorylate p66Shc in
HAEC, which leads to an increase of superoxide anions
and a reduction of NO [68]. p66Shc is an adaptor protein
that mediates vascular dysfunction in hypertensive mice
[70]. Phosphorylation of p66Shc during pathological
stretch disturbs the ROS balance as the superoxide
anion reacts with NO to generate ONOO− [71]. This re-
sults in reduced NO bioavailability and contributes to
endothelial dysfunction as ECs lose NO-dependent anti-
atherogenic properties [72]. The findings indicate that
pathological stretch is associated with excessive ROS
production in ECs that can induce oxidative stress and
eventually advance cardiovascular disease.
Interestingly, ECs have developed an adaptive mech-
anism of producing antioxidant enzymes during
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glutathione peroxidase enzyme can degrade accumulat-
ing H2O2 resulting from the reaction of superoxide
anion and NO that is involved in pro-inflammatory
gene activation, thereby serving as an adaptive mech-
anism to protect cells from stress conditions. Further-
more, heat shock proteins (such as HSP10) may be
upregulated in stretch-induced cells to ensure proper
protein folding in response to stress that is thought to
cause protein aggregation and misfolding [73]. Thus,
the expression of these proteins may serve as the cell’s
protection against cellular injury although we suggest
that their effect eventually wanes in response to the
sustained production of ROS.
Mechanical stretch promotes inflammation in ECs
In pathological stretch, IL-8 can be secreted from the
Weibel–Palade body’s storage granule that was highly exo-
cytosed in HUVECs [74]. In addition, IL-6 secretion has
been shown to be mediated by the inflammatory tran-
scription factor NFκB [75]. The activation of NFκB results
from the release of ROS to the cytoplasm that then reacts
with Cu/Zn superoxide dismutase to form H2O2 that can
subsequently activate NFκβ [70]. Activation of NFκβ also
activates adhesion molecules such as the vascular cell
adhesion molecule 1 (VCAM-1) and intercellular adhe-
sion molecule 1 (ICAM-1) that are pro-inflammatory.
Additionally, application of mechanical stretch on the co-
culture system of ECs and SMC showed that CD40 was
also highly expressed in HUVECs [76]. These surface
molecules exert pro-inflammatory responses by recruiting
monocytes or leukocytes, and their high expression pre-
disposes patients to atherosclerotic plaque development.
Taken together, evidence of expression of VCAM-1,
ICAM-1 and IL-6/8 supports the proposition that mechan-
ical stretch, especially at pathological intensity, stimulates
protein expression associated with monocyte, leukocyte
and T-cell recruitment and can lead to atherosclerosis as it
stimulates the invasion and accumulation of white blood
cells in the blood vessels (Table 1).
Apoptosis and survival of ECs during mechanical stretch
Cyclic stretch affects apoptosis and survival of ECs, and
this appears to be based on the magnitude and duration
of stretch applied to the cell (Table 1). Apoptosis of ECs
is involved in plaque development by inducing inflam-
matory cell infiltration into the sub-endothelial layer of
the vessel wall. In addition, luminal ECs in atheroscler-
otic plaques that undergo apoptosis are more likely to
cause plaque erosion and rupture [45]. Application of
physiological stretch on BAEC was found to reduce
apoptosis via P13K and Akt activation [45]. This can be
explained further by noting that Akt was phosphorylated
in 5 % stretch, whereas when 20 % stretch was appliedto HAEC, Akt was dephosphorylated [77]. Akt promotes
cell survival as it enables the phosphorylation of the pro-
apoptotic protein BAD from inducing cell death in
BAEC [78]. In addition, expression of NADPH oxidase
subunit p22phox in stretched ECs is found to increase
ECs survival as p22phox gene knockdown induces pro-
apoptotic caspase-3. The discrepancies between physio-
logical and pathological stretch in the promotion of
apoptosis indicate that physiological stretch plays a
vasculoprotective role whereas pathological stretch plays
a role in the promotion of EC apoptosis [77].
Pathological implications of mechanical stretch
Normal vascular function begins with a mechanical
stimulus that becomes converted into a cascade of
chemical events to activate protein signaling as a re-
sponse to the stimuli. As such, ECs are one of the com-
ponents in blood vessels that are highly organized to
sense and respond to normal forces. When unusual
conditions arise, such as mechanical overload due to
excessive and/or chronic stretch intensity, cells respond
with adaptive processes that can become maladaptive
and can lead to disease states. As has been mentioned
previously, pathological stretch activates different mecha-
nisms leading to significant changes in the phenotype of
the cell that may lead to endothelial dysfunction and
hence to vascular disease (Figs. 2 and 3).
As high-intensity stretch introduces a stressful envir-
onment to the blood vessels, they are modified to
accommodate this by a collective process that has been
termed ‘vascular remodeling’. This process involves vas-
cular alteration in the form of migration, proliferation,
apoptosis and ECM reorganization involving ECM syn-
thesis and degradation [79]. However, degradation of
ECM in blood vessels is related to the development of
atherosclerosis as a result of smooth muscle cells migrat-
ing into the intima layer due to degradation of the
internal elastic lamina in the tunica intima and the sub-
sequent initiation of plaque formation [46]. Chronic
hypertension, a state associated with prolonged patho-
logical stretch, promotes pro-inflammatory responses by
cytokines (IL-8, IL-6) and MCP-1 and results in recruit-
ment of neutrophils and monocytes to the vessel, leading
to the development of atherosclerotic plaques [80]. The
accumulation of inflammatory cells at the site of
inflammation acts as an initial event for fatty streak or
atherosclerotic lesion formation and later induces SMC
proliferation and migration into the intima layer lead-
ing to intimal thickening [81]. Furthermore, mechanical
stretch is found to increase EC stiffening which may
exacerbate atherosclerosis [82]. Interestingly, trans-
differentiation of ECs to SMCs has been observed when
stretch is applied to cells. Specifically, SMC marker

















Fig. 2 Pathological consequences of altered mechanical stretch.
Pathological stretch could change the hemodynamic properties
of blood flow in the vascular system. The excessive strain causes
cell deformation and the endothelial cell response activates
biochemical signaling. Vascular adaptation through remodeling
results in ECM synthesis and degradation, proliferation and
apoptosis to maintain the vascular physiological state. However,
persistent pathological mechanical stretch due to hypertension
triggers endothelial dysfunction, pro-inflammatory responses,
neointima formation, structural alteration, ROS formation and
arterial stiffening. These result in the formation of vascular
anomalies such as atherosclerosis, restenosis and aneurysms
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quent reduction in endothelial markers was observed
[83, 84]. The presence of SMC markers on EC suggests
EC plasticity towards SMC phenotype occurs during
mechanical stretch, and this may contribute to the de-
velopment of atherosclerosis.
As has been mentioned previously, pathological stretch
could increase ROS production. This will in turn induce
endothelial dysfunction and act as the initial step ofatherogenesis. Endothelial dysfunction is an early indicator
of atherogenesis that is characterized by reduced NO pro-
duction that promotes platelet aggregation, thrombus for-
mation and alterations in vasodilation [85]. Excessive ROS
production leads to oxidative stress, which in turn leads to
oxidation of low-density lipoproteins, the uptake of which
by macrophages is easily compared with non-oxidized
lipoproteins in the formation of atheroma. Furthermore,
ROS can also alter ECs such that they exhibit a pro-
inflammatory phenotype characterized by the overex-
pression of MCP-1 and VCAM-1 [71]. This attracts
inflammatory cells, such as white blood cells, and results
in the formation of fatty streaks on the tunica intima dur-
ing atherosclerosis development.
Stenosis is a common vascular pathology character-
ized by the narrowing of a blood vessel due to athero-
sclerosis. Stenosis is treated by the use of balloon
angioplasty or stents to widen the vessel. Balloon angio-
plasty reduces the recurrence of restenosis by 40 %,
whereas treatment using stents reduces the recurrence
of restenosis by 25 % [86]. It is thought that stretching
plays a role in this process by increasing cell prolifera-
tion and intimal thickening at the vascular graft area
after the treatment, although this has yet to be conclu-
sively proven [81, 87]. As previously mentioned, identi-
fication of the Egr-1 gene in stretched cells may hold
future therapeutic potential as this gene is involved in
cell proliferation and silencing it may prevent this
process [58].
Another vascular pathology that may be associated
with stretch is aneurysm formation. Aneurysms are
formed due to the weakening of blood vessels, and their
rupture in the brain is considered a cause of strokes. Ap-
proximately 2–3.2 % of the general population of the
world develops intracranial aneurysms, and the rupture
of aneurysms affects approximately 6 per 100,000 people
per year [88–90]. Excessive stress could exacerbate the
conditions leading to aneurysm rupture as there is a
weakening of the vascular structure due to ECM degrad-
ation by MMP and cell apoptosis. The rupture of brain
aneurysms has recently been reported to be caused by a
mechanical force against the thin aneurysm wall [91].
Thus, further study to elucidate mechanical stretch as
the etiology for aneurysm development and rupture may
assist in understanding aneurysm pathology.
Future research
The cells of the vascular system are exposed to complex
environments and interact with various cell types, hor-
mones, mechanical forces and other vasoactive substances.
Due to the complexity of the cellular environment, it is
particularly challenging to investigate specific outcomes
from mechanical stretch of ECs. Thus, the application of
stretch to ECs per se has unraveled protein signaling
Fig. 3 Summary of the mechanisms involved in human cerebral microvascular endothelial cells induced by mechanical stretching. Stretch stimuli
are sensed by mechanoreceptors of the endothelial cell that transduce downstream protein signals. This will result in gene activation and
increased protein synthesis that alters cell phenotype and function. However, different stretch intensity, magnitude and duration may activate
different mechanisms. Physiological stretch is beneficial in maintaining healthy blood vessels; however, pathological stretch, as is observed in
hypertension, could activate pathways leading to disease development. Thus, it is important to understand and elucidate the signaling involved
with these processes as this could aid in the identification of novel therapeutic approaches aimed at treating vascular related diseases. Ca2+
Calcium ion, ECM Extracellular matrix, EDHF Endothelium derived hyperpolarizing factor, EET Epoxyeicosatrienoic acid, eNOS Endothelial nitric
oxide synthase, ET-1 Endothelin 1, MCP-1 Monocyte chemoattractant protein-1, NO Nitric oxide, PECAM-1 Platelet endothelial cell adhesion
molecule 1, ROS Reactive oxygen species, SA channel Stretch activated channel, TK receptors Tyrosine kinase receptors, VCAM-1 Vascular cell
adhesion molecule-1, VE-cadherin Vascular endothelial cadherin, wPB Weibel-Palade Bodies
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consequences. It is therefore not surprising that designing
experiments that simulate the conditions that exist in the
vascular environment are near impossible. However, a
reductionist approach has provided insight into some of
mechanisms that can be pieced together to form a frag-
mented, although detailed, picture.
Shear stress and tensile stretch are two forces that
are exerted on the vascular system, but these have con-
trasting effects on ECs, thus making it challenging to
determine the precise mechanisms involved when both
stimuli are applied [92]. Therefore, a mechanical
device capable of combining forces has been ma-
nufactured to explore its simultaneous effect on ECs
[93, 92]. In addition, the application of co-culture
systems can simulate more accurate complex vascular
systems such as those in which ECs have close contact
with SMCs. These approaches are still limited, but they
may elucidate interactions between ECs and SMCsunder conditions of mechanical stress. Outcomes may
vary based on differences in stretch frequency, load
cycle, amplitude, substrate rigidity and cell confluence
[26, 34, 37, 94].
One recent addition to the “omics” suite dubbed
“mechanomics” involves generating tools to map global
molecular and cellular responses induced by mechanical
forces [95]. Application of these technologies could help
elucidate comprehensive patterns of expression of genes
(genomic), mRNA (transcriptomic), proteins (proteomic)
and metabolites (metabolomics); however, the spatio-
temporal nature of these technologies may be limiting.
These technologies undoubtedly rely on a significant
infrastructure and knowledge base, and, therefore, bio-
informatics is an invaluable tool in teasing out the mech-
anistic implications of the protein and gene expression
levels. As these fields continue to develop, combinations
of gene expression, protein expression, metabolite data
and transcriptomic data will provide a comprehensive
Jufri et al. Vascular Cell  (2015) 7:8 Page 10 of 12understanding of stretch biology that will better illustrate
the mechanotransduction processes [95].
Conclusion
Mechanical stretch involves various extracellular to
intracellular changes in the coordination of ECs that
leads to phenotypic changes in these cells. The response
is dynamic such that aberrant changes lead to an imbal-
ance in homeostasis and potentially lead to failure of
function or undesired effects that can lead to hyperten-
sion and atherosclerosis, among other pathologies. ECs
have complex adaptation mechanisms to counteract this
stressful state, and a better understanding of these would
be helpful in finding novel therapeutic approaches re-
lated to hypertension, atherosclerosis, restenosis and
aneurysm formation.
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